A citation-based method for searching scientific literature

Erasmia Sampani, Pantelis Sarafidis, Aikaterini Papagianni. Expert Opin Drug Saf 2020
Times Cited: 4







List of co-cited articles
11 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
75

Electrolyte and Acid-Base Disturbances in Patients with Diabetes Mellitus.
Biff F Palmer, Deborah J Clegg. N Engl J Med 2015
87
50

Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
Michael Fralick, Sebastian Schneeweiss, Elisabetta Patorno. N Engl J Med 2017
146
50

Shift to Fatty Substrate Utilization in Response to Sodium-Glucose Cotransporter 2 Inhibition in Subjects Without Diabetes and Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Tim Heise, Roberto Bizzotto, Andrea Mari, Thomas R Pieber, Elza Muscelli. Diabetes 2016
283
50

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
50

Renal Handling of Ketones in Response to Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 2 Diabetes.
Ele Ferrannini, Simona Baldi, Silvia Frascerra, Brenno Astiarraga, Elisabetta Barsotti, Aldo Clerico, Elza Muscelli. Diabetes Care 2017
78
50

Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats.
Rachel J Perry, Aviva Rabin-Court, Joongyu D Song, Rebecca L Cardone, Yongliang Wang, Richard G Kibbey, Gerald I Shulman. Nat Commun 2019
38
50

Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.
Ele Ferrannini, Elza Muscelli, Silvia Frascerra, Simona Baldi, Andrea Mari, Tim Heise, Uli C Broedl, Hans-Juergen Woerle. J Clin Invest 2014
634
50

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
560
50

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
50

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
50


SGLT2 Inhibitors May Predispose to Ketoacidosis.
Simeon I Taylor, Jenny E Blau, Kristina I Rother. J Clin Endocrinol Metab 2015
268
25

Anion-gap interpretation: the old and the new.
Michael Emmett. Nat Clin Pract Nephrol 2006
15
25

Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney.
Biff F Palmer, Deborah J Clegg, Simeon I Taylor, Matthew R Weir. J Diabetes Complications 2016
19
25

SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and Diagnosis.
Ronald M Goldenberg, Lori D Berard, Alice Y Y Cheng, Jeremy D Gilbert, Subodh Verma, Vincent C Woo, Jean-François Yale. Clin Ther 2016
108
25

Euglycaemic diabetic ketoacidosis.
J F Munro, I W Campbell, A C McCuish, L J Duncan. Br Med J 1973
155
25

Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
754
25

Hormonal control of ketogenesis.
J D McGarry, D W Foster. Adv Exp Med Biol 1979
12
25

Euglycaemic diabetic ketoacidosis: does it exist?
D Jenkins, C F Close, A J Krentz, M Nattrass, A D Wright. Acta Diabetol 1993
49
25

Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion.
Caroline Bonner, Julie Kerr-Conte, Valéry Gmyr, Gurvan Queniat, Ericka Moerman, Julien Thévenet, Cédric Beaucamps, Nathalie Delalleau, Iuliana Popescu, Willy J Malaisse,[...]. Nat Med 2015
390
25

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Pantelis Sarafidis, Charles J Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque,[...]. Nephrol Dial Transplant 2019
79
25



Cyclic AMP Regulates Key Features of Macrophages via PKA: Recruitment, Reprogramming and Efferocytosis.
Graziele L Negreiros-Lima, Kátia M Lima, Isabella Z Moreira, Bruna Lorrayne O Jardim, Juliana P Vago, Izabela Galvão, Lívia Cristina R Teixeira, Vanessa Pinho, Mauro M Teixeira, Michelle A Sugimoto,[...]. Cells 2020
14
25

Epigenetic regulation in monocyte/macrophage: A key player during atherosclerosis.
Su-Jie Jia, Ke-Qin Gao, Ming Zhao. Cardiovasc Ther 2017
21
25

Protective role of interleukin-10 in atherosclerosis.
Z Mallat, S Besnard, M Duriez, V Deleuze, F Emmanuel, M F Bureau, F Soubrier, B Esposito, H Duez, C Fievet,[...]. Circ Res 1999
568
25

Characterization of a novel, non-peptidyl antagonist of the human glucagon receptor.
M A Cascieri, G E Koch, E Ber, S J Sadowski, D Louizides, S E de Laszlo, C Hacker, W K Hagmann, M MacCoss, G G Chicchi,[...]. J Biol Chem 1999
74
25

Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms.
Masakazu Koshibu, Yusaku Mori, Tomomi Saito, Hideki Kushima, Munenori Hiromura, Michishige Terasaki, Michiya Takada, Tomoyasu Fukui, Tsutomu Hirano. Am J Physiol Endocrinol Metab 2019
8
25

Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration.
L B Knudsen, P F Nielsen, P O Huusfeldt, N L Johansen, K Madsen, F Z Pedersen, H Thøgersen, M Wilken, H Agersø. J Med Chem 2000
451
25

Insulin Secretion Depends on Intra-islet Glucagon Signaling.
Berit Svendsen, Olav Larsen, Maria Buur Nordskov Gabe, Charlotte Bayer Christiansen, Mette M Rosenkilde, Daniel J Drucker, Jens Juul Holst. Cell Rep 2018
122
25

Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients.
K Eeg-Olofsson, J Cederholm, P M Nilsson, B Zethelius, L Nunez, S Gudbjörnsdóttir, B Eliasson. Diabetologia 2009
155
25

The New Biology and Pharmacology of Glucagon.
T D Müller, B Finan, C Clemmensen, R D DiMarchi, M H Tschöp. Physiol Rev 2017
122
25

Adeno-associated virus vector-mediated interleukin-10 gene transfer inhibits atherosclerosis in apolipoprotein E-deficient mice.
T Yoshioka, T Okada, Y Maeda, U Ikeda, M Shimpo, T Nomoto, K Takeuchi, M Nonaka-Sarukawa, T Ito, M Takahashi,[...]. Gene Ther 2004
63
25

Glucagon and heart in type 2 diabetes: new perspectives.
Antonio Ceriello, Stefano Genovese, Edoardo Mannucci, Edoardo Gronda. Cardiovasc Diabetol 2016
41
25

Anti-inflammatory cytokines in subclinical carotid atherosclerosis.
Wojciech Ambrosius, Radoslaw Kazmierski, Slawomir Michalak, Wojciech Kozubski. Neurology 2006
16
25


The physiology of glucagon.
Gerald J Taborsky. J Diabetes Sci Technol 2010
42
25

Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice.
Gene C Webb, Murtaza S Akbar, Chongjian Zhao, Hewson H Swift, Donald F Steiner. Diabetes 2002
72
25

Forskolin attenuates the NLRP3 inflammasome activation and IL-1β secretion in human macrophages.
Yan Chen, Jian Guo Wen, Jin Jin Feng, Yi He Wang, Tian Fang Li, Katariina Nurmi, Kari K Eklund, Dong Xing. Pediatr Res 2019
9
25

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Paul M Ridker, Brendan M Everett, Tom Thuren, Jean G MacFadyen, William H Chang, Christie Ballantyne, Francisco Fonseca, Jose Nicolau, Wolfgang Koenig, Stefan D Anker,[...]. N Engl J Med 2017
25


2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetologia 2020
171
25

Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.
Hannes Manell, Johan Staaf, Levon Manukyan, Hjalti Kristinsson, Jing Cen, Rasmus Stenlid, Iris Ciba, Anders Forslund, Peter Bergsten. J Clin Endocrinol Metab 2016
39
25

Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production.
Aurora Merovci, Carolina Solis-Herrera, Giuseppe Daniele, Roy Eldor, Teresa Vanessa Fiorentino, Devjit Tripathy, Juan Xiong, Zandra Perez, Luke Norton, Muhammad A Abdul-Ghani,[...]. J Clin Invest 2014
477
25

Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes.
Christopher Heeschen, Stefanie Dimmeler, Christian W Hamm, Stephan Fichtlscherer, Eric Boersma, Maarten L Simoons, Andreas M Zeiher. Circulation 2003
280
25

SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats.
Masanori Yokono, Toshiyuki Takasu, Yuka Hayashizaki, Keisuke Mitsuoka, Rumi Kihara, Yuko Muramatsu, Sousuke Miyoshi, Atsuo Tahara, Eiji Kurosaki, Qun Li,[...]. Eur J Pharmacol 2014
119
25

Effect of ketone infusions on amino acid and nitrogen metabolism in man.
R S Sherwin, R G Hendler, P Felig. J Clin Invest 1975
329
25

Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.
Hyun Mi Kang, Seon Ho Ahn, Peter Choi, Yi-An Ko, Seung Hyeok Han, Frank Chinga, Ae Seo Deok Park, Jianling Tao, Kumar Sharma, James Pullman,[...]. Nat Med 2015
534
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.